Clinical Utility Study Indicates Potential for TruGraf™ Test to Replace Surveillance Biopsies in Kidney Transplant Recipients with Stable Renal Function
November 28, 2017 11:51 ET
|
Transplant Genomics Inc.
Mansfield, Nov. 28, 2017 (GLOBE NEWSWIRE) -- MANSFIELD, MA – Transplant Genomics Inc. (TGI), a molecular diagnostics company committed to improving organ transplant outcomes, has published a...